Akebia Therapeutics, Inc. (AKBA): Weighted Average Diluted Shares
257.16M
Year ended 2025-12-31
+12.1%
3-year compound annual growth
+13.2%
5-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 257.16M | +21.9% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | 210.95M | +12.5% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | 187.47M | +2.6% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | 182.78M | +10.1% | 2024-03-14, From 2022-01-01 |
| 2021-12-31 | 165.95M | +19.9% | 2023-08-28, From 2021-01-01 |
| 2020-12-31 | 138.46M | +16.9% | 2023-08-28, From 2020-01-01 |
| 2019-12-31 | 118.40M | n/a | 2022-03-01, From 2019-01-01 |